Every year, from December to February, is the high influenza season. In the two years since the new crown virus epidemic, the coexistence of new crown and influenza has been a hot topic of public opinion in these two years. Domestic IVD companies have also been developing "multi-test" reagents.

The issue of co-infection or coexistence between the two has been a common theme in academic journals and papers, and cases of Flurona have been identified in countries including the United States, Israel, Brazil, the Philippines and Hungary, some even before the term was coined.

On January 3 of this year, the Global Times reported a case of Flurona in Israel as "the first case in the world". The name "Flurona" refers to the combination of "Flu" and "Coronavirus".

The reported case further illustrates the current critical situation of the new crown epidemic and influenza worldwide.

In an interview with the media, Israeli physician Vizhnitser predicted that co-infections may continue to occur. Although it may continue to occur, there is no need to worry, as studies have surfaced that people who have been vaccinated against neo-crown have not developed symptoms severe enough to cause death after a co-infection.

So what are the possible changes in the New Crown Nucleic Acid Rapid Test under the double whammy of New Crown and influenza?

1, the new crown nucleic acid rapid test product sensitivity will be further enhanced. With the continuous mutation of the virus strains, the new crown nucleic acid rapid test reagents are suitable for the problem has been the focus of attention. New crown nucleic acid rapid test reagents must be optimized in time with the variation of the strain, which is very necessary. And its as the first line of defense for the prevention and control of the epidemic, but also the key to the prevention and control of the epidemic.

2. New crown and influenza are prevalent together, and reagent iteration is imperative. The face of the new crown and the double attack of influenza, in the case of the two symptoms are very similar, how to quickly determine what kind of virus infected, good gate control, is now very important. In this context, the research and development of the multiplex test reagent should be promoted, and we have already invested a lot of manpower and resources in the research and development of the reagent, and believe that in the near future, it will be able to help prevention and control with a strong posture.

3, the new crown nucleic acid rapid detection efficiency mentioned again to become inevitable. In the popularity of both, the fastest speed and highest quality of sub-testing is also an important part of the current prevention and control can not be put aside.

And to improve efficiency, high-sensitivity reagents, high-efficiency reagents must be based on the previous one to a higher level. Currently most of the new crown nucleic acid rapid test reagents sensitivity are in 500 copies, I believe that the future sensitivity will be further improved, with fully automated nucleic acid extraction instrument and high efficiency amplification instrument, I think the new crown nucleic acid rapid test efficiency will also mention again.

In addition to the changes in the New Crown Nucleic Acid Rapid Test, our personal prevention and control measures should also be further improved. We should always pay attention to the prevention and control news announced by the National Health Commission, improvise, do a good job of personal protection, and gather the strength of all people to overcome the epidemic.